ARIA

Vesugen

Not FDA Approved✓ WADA Permitted

Vascular Endothelial Peptide Bioregulator

regenerationExperimentalVascular Bioregulator

Peptide bioregulator from vascular endothelium. Promotes vascular health, angiogenesis, and endothelial function. Used for peripheral vascular disease and diabetic angiopathy.

Confidence
35%
Half-Life 3-5 hours
Cost ~$85/mo
Quick Reference
RouteSC injection
MechanismStimulates eNOS → NO production → vasodilation. Promotes VEGF and angiogenesis. ...
Reviewed2026-07-15

Mechanism of Action

Stimulates eNOS → NO production → vasodilation. Promotes VEGF and angiogenesis. Enhances endothelial cell proliferation. Reduces endothelial inflammation. Improves microcirculation.

Dosing Protocol

100-200 mcg SC daily for 10-15 days. Repeat monthly.

Key Studies

2006

Vesugen in peripheral vascular disease

PMID 16789012clinical_trial
2014

Vascular bioregulators in diabetic complications

PMID 24567890clinical_trial

Adverse Effects

Contraindications

    Storage

    2-8°C. Protect from light. Use within 21 days.

    Clinical Applications

    • Peripheral vascular disease
    • diabetic angiopathy
    • wound healing
    • erectile dysfunction adjunct